Cargando…

Peptide Therapeutics 2.0

Detalles Bibliográficos
Autores principales:	de la Torre, Beatriz G., Albericio, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287585/ https://www.ncbi.nlm.nih.gov/pubmed/32414106 http://dx.doi.org/10.3390/molecules25102293

Ejemplares similares

Practical Protocols for Solid-Phase Peptide Synthesis 4.0
por: de la Torre, Beatriz G., et al.
Publicado: (2022)

Protocol for efficient solid-phase synthesis of peptides containing 1-hydroxypyridine-2-one (1,2-HOPO)
por: Al Shaer, Danah, et al.
Publicado: (2020)

Naturally Occurring Oxazole-Containing Peptides
por: Mhlongo, Jessica T., et al.
Publicado: (2020)

Revisiting NO(2) as Protecting Group of Arginine in Solid-Phase Peptide Synthesis
por: Alhassan, Mahama, et al.
Publicado: (2020)

2017 FDA Peptide Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2018)

Antimicrobial Peptide Synergies for Fighting Infectious Diseases
por: Mhlongo, Jessica T., et al.
Publicado: (2023)

Advances in Antibody Design and Antigenic Peptide Targeting 2.0
por: Trier, Nicole Hartwig, et al.
Publicado: (2023)

Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0
por: Tang, Chih-Hsin
Publicado: (2020)

2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2020)

2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2021)

2021 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2022)

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2023)

Membrane–Peptide Interactions: From Basics to Current Applications 2.0
por: Gonçalves, Sónia, et al.
Publicado: (2023)

Atherosclerosis: From Molecular Biology to Therapeutic Perspective 2.0
por: Perrotta, Ida
Publicado: (2022)

Novel Biomimetic Human TLR2-Derived Peptides for Potential Targeting of Lipoteichoic Acid: An In Silico Assessment
por: Devnarain, Nikita, et al.
Publicado: (2021)

Amino-Li-Resin—A Fiber Polyacrylamide Resin for Solid-Phase Peptide Synthesis
por: Akintayo, Damilola C., et al.
Publicado: (2022)

Scope and Limitations of γ-Valerolactone (GVL) as a Green Solvent to be Used with Base for Fmoc Removal in Solid Phase Peptide Synthesis
por: Kumar, Ashish, et al.
Publicado: (2019)

Extremofiles 2.0
por: Amils, Ricardo, et al.
Publicado: (2021)

Photosynthesis 2.0
por: Cazzaniga, Stefano, et al.
Publicado: (2023)

Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0
por: Zannetti, Antonella
Publicado: (2023)

A Practical Peptide Synthesis Workflow Using Amino-Li-Resin
por: Akintayo, Damilola Caleb, et al.
Publicado: (2022)

Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection
por: Nandhini, K. P., et al.
Publicado: (2023)

New Sources, Differentiation, and Therapeutic Uses of Mesenchymal Stem Cells 2.0
por: Jung, Sung-Chul, et al.
Publicado: (2023)

The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0
por: Abate, Carmen, et al.
Publicado: (2023)

PLoS Biology 2.0
por: Eisen, Jonathan A
Publicado: (2008)

Introducing Neurosurgery 2.0
por: Kubben, Pieter L.
Publicado: (2010)

Plasma Biology 2.0
por: Sakudo, Akikazu, et al.
Publicado: (2022)

Bioactive Oxadiazoles 2.0
por: Palumbo Piccionello, Antonio
Publicado: (2022)

Orchid Biochemistry 2.0
por: Chen, Jen-Tsung
Publicado: (2022)

The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2020)

The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2018)

The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: G. de la Torre, Beatriz, et al.
Publicado: (2019)

The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type
por: de la Torre, Beatriz G., et al.
Publicado: (2017)

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2021)

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2022)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2023)

Biology Education Research 2.0
por: Dolan, Erin L.
Publicado: (2015)

Microgravity and Space Medicine 2.0
por: Grimm, Daniela
Publicado: (2022)

Biomarkers in Rare Diseases 2.0
por: Bax, Bridget E.
Publicado: (2022)

Targeting MAPK in Cancer 2.0
por: Rovida, Elisabetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7mgju0ve167lga5m8agb9ie3ne